Anti-Convulsive and Anti-Epileptic Properties of Brivaracetam (Ucb 34714), a High-Affinity Ligand for the Synaptic Vesicle Protein, SV2A

British Journal of Pharmacology - United States
doi 10.1038/bjp.2008.198
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expression in the Retina

PLoS ONE
Multidisciplinary
2009English

The Vesicle Protein SAM-4 Regulates the Processivity of Synaptic Vesicle Transport

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2014English

A Systematic Review of Anti-Malarial Properties, Immunosuppressive Properties, Anti-Inflammatory Properties, and Anti-Cancer Properties of Artemisia Annua

Electronic physician
2016English

Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs

Diagnostics
Clinical Biochemistry
2019English

A High-Affinity Fully Human Anti-Il-6 mAb, 1339, for the Treatment of Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2009English

NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

European Journal of Immunology
AllergyImmunology
2018English

Structure-Guided Design of a High Affinity Ligand for a Riboswitch

RNA
Molecular Biology
2019English

Anti-Inflammatory and Anti-Oxidant Properties: Is There a Link?

International Journal of Risk and Safety in Medicine
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy